限制平均存活时间方法与时间变化的系数 考克斯模型用于量化危害不成比例时的治疗效果
Tianyuan Gu1, Zhaojin Chen1, Yu Yang Soon2
1Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive, #10-01, Singapore, 117549, Singapore.
BMC medical research methodology
|July 2, 2025
概括
考克斯时间变化系数 (TVC) 模型有效地总结了使用预期寿命比率 (LER) 和预期寿命差异 (LED) 在非比例危险 (PH) 设置中的治疗效果,在模拟中表现优于灵活的参数模型.
科学领域:
- 生物统计学 生物统计学
- 生存分析的分析.
- 临床试验 临床试验
背景情况:
- 考克斯的时间变量系数 (TVC) 模型在不成比例的危险 (PH) 中未得到充分利用.
- 限制平均存活时间 (RMST) 通常用于非PH,通过预期寿命比率 (LER) 和预期寿命差异 (LED) 来量化治疗效应.
研究的目的:
- 探索一个扩展的Cox TVC模型,用于在非PH环境中产生LER和LED.
- 为了将Cox TVC模型与灵活的参数模型 (FPM) 进行治疗效果估计.
主要方法:
- 一项模拟研究根据比例和非比例的危险假设将Cox TVC和FPM进行了比较.
- 使用了分片指数分布和统一的审查模式.
- 评估包括对鼻癌进行随机临床试验,治疗效益增加.
主要成果:
- 考克斯TVC在非PH条件下表现优于FPM,偏差较小,覆盖范围更好.
- 在交叉或分离的生存曲线的场景中,Cox TVC表现出更高的功率.
- 实际数据显示,与Cox TVC相比,FPM的LER和LED估计略高一些.
结论:
- 考克斯TVC模型是使用LER和LED在非PH场景中总结治疗效果的实用方法.
- 在特定的里程碑上补充危险比率 (HR) 可以帮助早期检测治疗差异.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
299
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
299
Assumptions of Survival Analysis
199
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
199
The Mantel-Cox Log-Rank Test
576
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
576
Kaplan-Meier Approach
277
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
277
Introduction To Survival Analysis
407
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
407
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458


